Overview of Lenalidomide
What is Lenalidomide? Overview
| Property | Description |
|---|---|
| Active ingredient | Lenalidomide |
| Form | Capsules (Oral dosage form) |
| Pharmacological class | Immunomodulatory Drug (IMiD), Antineoplastic Agent |
| General purpose | Management of hematological malignancies |
| Origin | Synthetic thalidomide analog |
Lenalidomide: A Synthetic Immunomodulatory Drug (IMiD)
Lenalidomide is a potent, synthetic compound classified as both an Antineoplastic Agent and an Immunomodulatory Drug (IMiD). The medicine is a prescription-only substance whose sole active ingredient is Lenalidomide. Structurally, it is derived from the older drug thalidomide, making it a thalidomide analog and a glutamic acid derivative. This purposeful chemical modification was developed to achieve highly targeted therapeutic effects.
The drug’s mechanism involves selective degradation of certain proteins to induce antiproliferative effects and immunomodulation. This clinically recognized action indicates that the medicine works by targeting specific molecular pathways that regulate cell growth and immune function, differentiating it from traditional, less selective therapies.
Classification, Form, and General Purpose
Lenalidomide is exclusively an oral dosage form, supplied as a single-ingredient product within capsules, enabling simple oral administration. The medicine contains the active ingredient and standard pharmaceutical excipients; it is not a combination drug. A unique factor differentiating this INN is that, due to its high potency, the drug is typically available only through a special restricted distribution program (e.g., REMS), underscoring the need for strict medical oversight and patient education.
Its classification as an Antineoplastic Agent points directly to its general therapeutic purpose: it is fundamentally used to assist in the management of specific conditions characterized by the excessive or abnormal proliferation of cells, such as certain hematological malignancies.
Lenalidomide functions as an agent that enhances immune cell function and inhibits pro-inflammatory factors. This indicates that Lenalidomide's general benefit comes from modifying the disease environment by boosting certain protective immune responses and simultaneously restricting the ability of abnormal cells to grow and sustain themselves.
